Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new version entry, Revision: v3.4.3, was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:30.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision (v3.4.2) was added to the record history, and an earlier revision (v3.4.1) was removed, along with a government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T14:25:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice was added and the page revision was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:40:24.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include Show glossary, color-coded change indicators (green/red highlights), and revised revision notes; core study data and functionality remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T06:31:49.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.4' was added to the record history, replacing the earlier 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:33:22.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.3 is now displayed and the HHS Vulnerability Disclosure footer link was removed; these are cosmetic changes that do not affect study data or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:22:24.000Z thumbnail image

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.